| 1 | A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis | 1.7 | 6 | Citations (PDF) |
| 2 | Increased local DNA methylation disorder in AMLs with DNMT3A-destabilizing variants and its clinical implication | 10.8 | 13 | Citations (PDF) |
| 3 | Single cell RNA sequencing of haematopoietic cells in fresh and frozen human atheroma tissue | 5.7 | 5 | Citations (PDF) |
| 4 | Clonal hematopoiesis: elements associated with clonal expansion and diseases | 1.4 | 10 | Citations (PDF) |
| 5 | Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 womenBlood, 2025, 146, 1078-1087 | 3.6 | 26 | Citations (PDF) |
| 6 | TET2-mutant myeloid cells mitigate Alzheimer’s disease progression via CNS infiltration and enhanced phagocytosis in mice | 11.6 | 22 | Citations (PDF) |
| 7 | Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women | 0.7 | 25 | Citations (PDF) |
| 8 | Individual and Neighborhood-level Socioeconomic Status and Somatic Mutations Associated With Increased Risk of Cardiovascular Disease and Mortality: A Cross-Sectional Analysis in the Women's Health Initiative | 1.2 | 3 | Citations (PDF) |
| 9 | Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias | 2.6 | 82 | Citations (PDF) |
| 10 | Radon Exposure, Clonal Hematopoiesis, and Stroke Susceptibility in the Women's Health Initiative | 0.7 | 11 | Citations (PDF) |
| 11 | Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study | 2.6 | 55 | Citations (PDF) |
| 12 | Determinants of mosaic chromosomal alteration fitness | 10.8 | 11 | Citations (PDF) |
| 13 | Epigenetic and proteomic signatures associate with clonal hematopoiesis expansion rate | 13.3 | 16 | Citations (PDF) |
| 14 | Dynamics of clonal hematopoiesis and risk of hematologic malignancy | 0.9 | 4 | Citations (PDF) |
| 15 | Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions | 4.9 | 8 | Citations (PDF) |
| 16 | Clonal Hematopoiesis and Its Impact on Human Health | 10.5 | 66 | Citations (PDF) |
| 17 | A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets | 3.6 | 80 | Citations (PDF) |
| 18 | Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis | 30.7 | 112 | Citations (PDF) |
| 19 | Clonal haematopoiesis and risk of chronic liver disease | 30.7 | 209 | Citations (PDF) |
| 20 | The genetic determinants of recurrent somatic mutations in 43,693 blood genomes | 8.1 | 13 | Citations (PDF) |
| 21 | Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis | 5.3 | 313 | Citations (PDF) |
| 22 | Clonal hematopoiesis is associated with protection from Alzheimer’s disease | 22.6 | 153 | Citations (PDF) |
| 23 | Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease | 0.7 | 159 | Citations (PDF) |
| 24 | Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood | 3.1 | 8 | Citations (PDF) |
| 25 | Genetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk | 6.6 | 80 | Citations (PDF) |
| 26 | Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes | 6.6 | 35 | Citations (PDF) |
| 27 | Clonal Hematopoiesis Is Associated With Higher Risk of Stroke | 4.4 | 216 | Citations (PDF) |
| 28 | Association of clonal hematopoiesis with chronic obstructive pulmonary diseaseBlood, 2022, 139, 357-368 | 3.6 | 237 | Citations (PDF) |
| 29 | Clonal Hematopoiesis: Confluence of Malignant and Nonmalignant Diseases | 2.8 | 11 | Citations (PDF) |
| 30 | Clonal Hematopoiesis Analyses in Clinical, Epidemiologic, and Genetic Aging Studies to Unravel Underlying Mechanisms of Age-Related Dysfunction in Humans | 2.5 | 28 | Citations (PDF) |
| 31 | Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential | 8.1 | 86 | Citations (PDF) |
| 32 | Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self | 8.6 | 108 | Citations (PDF) |
| 33 | Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics | 4.1 | 67 | Citations (PDF) |
| 34 | TET2-mutant clonal hematopoiesis and risk of goutBlood, 2022, 140, 1094-1103 | 3.6 | 158 | Citations (PDF) |
| 35 | Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease | 10.8 | 97 | Citations (PDF) |
| 36 | Preventive Cardio-Oncology: Cardiovascular Disease Prevention in Cancer Patients and Survivors | 0.6 | 8 | Citations (PDF) |
| 37 | Insights into clonal hematopoiesis and its relation to cancer risk | 2.4 | 29 | Citations (PDF) |
| 38 | Clonal hematopoiesis associated with epigenetic aging and clinical outcomes | 4.8 | 136 | Citations (PDF) |
| 39 | ZBTB33
Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing | 2.0 | 42 | Citations (PDF) |
| 40 | Inherited causes of clonal haematopoiesis in 97,691 whole genomes | 30.7 | 736 | Citations (PDF) |
| 41 | Clonal hematopoiesis and non-hematologic disorders | 3.6 | 103 | Citations (PDF) |
| 42 | Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD | 0.7 | 87 | Citations (PDF) |
| 43 | Clonal Hematopoiesis | 0.7 | 240 | Citations (PDF) |
| 44 | Clonal hematopoiesis in human aging and disease | 26.1 | 1,159 | Citations (PDF) |
| 45 | Genetic regulation of gene expression and splicing during a 10-year period of human aging | 4.8 | 85 | Citations (PDF) |
| 46 | Biological implications of clonal hematopoiesis | 0.6 | 27 | Citations (PDF) |
| 47 | Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer | 8.4 | 70 | Citations (PDF) |
| 48 | Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease | 25.1 | 380 | Citations (PDF) |
| 49 | PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cellsBlood, 2018, 132, 1095-1105 | 3.6 | 222 | Citations (PDF) |
| 50 | Clonal Hematopoiesis | 1.9 | 59 | Citations (PDF) |
| 51 | Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma | 12.4 | 471 | Citations (PDF) |
| 52 | Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease | 26.4 | 2,612 | Citations (PDF) |
| 53 | Clonal Hematopoiesis and Atherosclerosis | 26.4 | 36 | Citations (PDF) |
| 54 | Clonal hematopoiesis | 2.3 | 122 | Citations (PDF) |
| 55 | Clonal Hematopoiesis Associated with Adverse Outcomes Following Autologous Stem Cell Transplantation for Non-Hodgkin LymphomaBlood, 2016, 128, 986-986 | 3.6 | 3 | Citations (PDF) |
| 56 | PPM1D Truncating Mutations Confer Chemotherapy Resistance in Hematopoietic Stem Cells, Which Is Reversible By PPM1D InhibitionBlood, 2016, 128, 740-740 | 3.6 | 0 | Citations (PDF) |
| 57 | Clonal Hematopoiesis and Blood-Cancer Risk | 26.4 | 66 | Citations (PDF) |
| 58 | Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes | 26.4 | 4,714 | Citations (PDF) |
| 59 | Mutations in G protein β subunits promote transformation and kinase inhibitor resistance | 22.6 | 135 | Citations (PDF) |
| 60 | Clonal Hematopoiesis with Somatic Mutations Is a Common, Age-Related Condition Associated with Adverse OutcomesBlood, 2014, 124, 840-840 | 3.6 | 1 | Citations (PDF) |
| 61 | Janus-like opposing roles of CD47 in autoimmune brain inflammation in
humans and mice | 5.9 | 167 | Citations (PDF) |
| 62 | The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors | 5.2 | 1,611 | Citations (PDF) |
| 63 | Macrophages as mediators of tumor immunosurveillance | 5.7 | 239 | Citations (PDF) |
| 64 | Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 | 8.7 | 721 | Citations (PDF) |
| 65 | Hematopoietic Stem and Progenitor Cells and the Inflammatory Response | 2.6 | 19 | Citations (PDF) |
| 66 | CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells | 23.4 | 1,702 | Citations (PDF) |
| 67 | CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis | 23.4 | 1,538 | Citations (PDF) |
| 68 | Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias | 5.2 | 159 | Citations (PDF) |
| 69 | Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease | 2.6 | 26 | Citations (PDF) |
| 70 | Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased Tissue | 20.5 | 2 | Citations (PDF) |
| 71 | Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations | 10.8 | 4 | Citations (PDF) |
| 72 | Human plasma proteomic profile of clonal hematopoiesis | 10.8 | 7 | Citations (PDF) |
| 73 | Phosphatidylcholine synthesis inhibition diminishes ASXL1 and DNMT3a mutation driven clonal hematopoiesis | 3.6 | 0 | Citations (PDF) |
| 74 | Metformin Does Not Significantly Alter Longitudinal Dynamics of Clonal Hematopoiesis | 4.5 | 0 | Citations (PDF) |
| 75 | Clonal hematopoiesis associates with prevalent and incident cardiometabolic disease in a cardiac catheterization cohort | 1.5 | 2 | Citations (PDF) |
